| Business Summary | | Wasatch
Pharmaceutical
Inc.,
researches
and
develops
dermatology
products.
The
Company,
organized
as
Ceron
Oil
Company
on
March
25,
1980,
was
engaged
in
oil
and
gas
operations
until
its
acquisition
of
Medisys
Research
Group,
Inc.
on
December
29,
1995.
During
December
1985,
the
two
oil
and
gas
wells
in
which
the
Company
had
an
interest
were
plugged
and
abandoned
due
to
the
depletion
of
reserves
and
economic
conditions
in
the
industry.
Since
that
time,
the
business
activity
of
the
Company,
including
the
acquisition,
development
and
promotion
of
oil
and
gas
properties,
have
been
conducted
on
a
limited
scale
with
primary
emphasis
on
maintaining
assets
held
by
the
Company.
The
continuing
operations
of
the
Company
consist
of
the
operation
of
its
two
wholly
owned
subsidiaries,
Medisys
and
American
Institute
of
Skin
Care
Inc.
(AISC). | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | WSPH
has
developed
proprietary
technology
for
the
treatment
of
various
skin
disorders
and
operates
two
prototype
treatment
clinics
in
Utah.
For
the
six
months
ended
6/30/01,
revenues
totaled
$33
thousand,
up
from
$14
thousand.
Net
loss
totaled
$1.8
million,
up
from
$828
thousand.
Revenues
reflect
benefits
from
the
marketing
efforts
for
the
Internet
and
Utah
clinics.
Net
loss
reflects
increased
clinic
salaries
and
personnel
costs
and
costs
related
to
start-up
operations. | More
from
Market Guide: Significant
Developments |
| | | | FY1999 Pay | |
| Gary Heesch, 63 Pres,
CEO, Director | $150K | David Giles, 54 CFO,
Sec. | 150K | Michael Fleming VP-Bus.
Devel. | -- | Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|